Thyroid eye disease (TED) is evolving rapidly in how we diagnose and manage it, especially with the introduction of targeted biologic therapies. While systemic corticosteroids and radiation once dominated treatment, newer immunomodulatory options are reshaping the clinical landscape and offering potential disease-modifying outcomes. Staying updated on these advancements is essential for optimizing patient care and preventing long-term morbidity. Take today’s Quick Question to check your clinical recall.
(Scroll down to answer the question) References : Frontiers in Ophthalmology & Eye ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no explicit or implied warranties about the information's suitability, reliability, or adequacy, including data visualization elements and graphics. We do not endorse…
